Koninklijke DSM N.V. Stock Other OTC
Equities
RDSMY
US7802491081
Consumer Goods Conglomerates
Sales 2024 * | 12.67B 13.5B | Sales 2025 * | 13.32B 14.19B | Capitalization | 27.62B 29.42B |
---|---|---|---|---|---|
Net income 2024 * | 447M 476M | Net income 2025 * | 785M 836M | EV / Sales 2024 * | 2.42 x |
Net Debt 2024 * | 3.01B 3.21B | Net Debt 2025 * | 2.7B 2.88B | EV / Sales 2025 * | 2.28 x |
P/E ratio 2024 * |
58.1
x | P/E ratio 2025 * |
34.7
x | Employees | - |
Yield 2024 * |
2.35% | Yield 2025 * |
2.38% | Free-Float | 25.03% |
Latest transcript on Koninklijke DSM N.V.
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 57 | 89-12-31 | |
Ralf Schmeitz
DFI | Director of Finance/CFO | - | 23-08-31 |
Sarah Reisinger
CTO | Chief Tech/Sci/R&D Officer | 45 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 63 | 23-01-31 | |
Thomas Leysen
CHM | Chairman | 63 | 23-01-31 |
Director/Board Member | 62 | 23-01-31 |
1st Jan change | Capi. | |
---|---|---|
+12.65% | 865B | |
0.00% | 239B | |
+16.01% | 167B | |
-7.37% | 124B | |
+31.07% | 82.45B | |
-4.38% | 74.34B | |
-15.60% | 50.62B | |
-20.32% | 41.22B | |
+22.96% | 33.68B |